Blog

  • Dakota Johnson Is Getting Ready to Shoot Directorial Feature Debut

    Dakota Johnson Is Getting Ready to Shoot Directorial Feature Debut

    “Madame Web” star Dakota Johnson, attending the Karlovy Vary Film Festival where she is set to receive the event’s prestigious President’s Award, is close to locking in final details for her directorial feature debut.

    Speaking with Variety in the Czech spa town, the actor says her debut is a project “very close to her heart.” The film is one she is working on alongside “Cha Cha Real Smooth” co-star Vanessa Burghardt, who she calls “an incredible autistic actress.” 

    “I’ve always felt that I’m not ready to direct a feature,” she continues. “I don’t have the confidence, but, with her, I feel very protective and I know her very well. I can see this world, so I just won’t let anybody else do it. That’s the real answer.”

    On top of receiving the award, the “50 Shades of Grey” alum is at the festival with two films: Celine Song’s three-hander romance “Materialists,” in which she stars alongside Chris Evans and Pedro Pascal, and Michael Angelo Covino’s Cannes sensation “Splitsville,” which she also produced under her TeaTime Pictures banner.

    Johnson plays a matchmaker in Song’s sophomore effort and, when asked about the matchmaking qualities required of a producer, the actor says she “cares a lot about how people get along on a set and how people collaborate.” “If there’s not a healthy collaboration, if it’s not a good match, then it’s not a good match. And we really don’t move forward if it’s not a good match,” she emphasizes. “I can’t waste time on toxic sets anymore, or in situations that are not fun or fulfilling or healthy. That’s one of the perks of [producing], because I get to put amazing people together and make something.” 

    Speaking about what she considers a toxic set to be, the actor says that she doesn’t want to face “anybody who’s mean or condescending or unkind.”

    “I don’t want to face people who are not willing to collaborate,” she continues. “And then there are obvious things. We all know what a toxic set is by now. We’re artists, so there’s room for expansive personalities, and we’re working with emotions. I love a healthy argument on a set, and I also believe that the most excellent idea wins. It’s not a fight. It’s not a race. It’s a collaboration.” 

    When it comes to standing up for herself when such toxic situations arise, Johnson says she feels she was “pretty vocal” about her feelings from a very young age. “I think now, just being in the position of being a producer and developing my own films, I can choose all the people who are in it, and that makes a huge difference.”

    As someone who has navigated a wide gamut of films within the industry, from producing and starring in indie productions like “Am I Ok?” to major studio projects like “Madame Web,” how does Johnson perceive the idea of success when it comes to filmmaking? “I think that the barometer for that is shifting right now,” she answers. 

    “It’s hard to measure success based on box office numbers now because it’s so all over the place,” she adds. “[‘Jurassic World Rebirth’] slayed, and of course, they knew that it was going to do really well, but it did so well. I feel so excited that people are going to the movie theater. Even ‘Materialists’ did so well for a tiny little movie, and that’s really, really exciting.”

    She continues by saying that success, to her, is measured by “people who felt something” when watching a film or films that are meaningful to audiences. “Honestly, it’s a success just getting a movie finished. It’s really hard to make movies right now and to get people to believe in what you want to say. I don’t think movies will save the world, by no means, but I do think it’s nice to have them around,” she concludes.

    Talking about the roles she would still love to play, the actor says she’s itching to play a “psychopath” and “would love to do an action film.” “I’m open to anything. Certain things [just have] to align.”

    As for her next acting project, Johnson just wrapped shooting Amazon MGM Studios’ film adaptation of Colleen Hoover’s best-selling psychological thriller “Verity,” directed by Michael Showalter and also starring Josh Hartnett and Anne Hathaway. Of taking on another wildly beloved book adaptation over a decade after the “50 Shades” series, the actor says adaptations can be hard because “sometimes a book doesn’t exactly translate to the screen.”

    Johnson brought up Maggie Gyllenhaal’s “The Lost Daughter,” an adaptation of Elena Ferrante’s eponymous novel, saying the actor-turned-director “was able to really go into her imagination and soul and put her taste on everything. When that can happen, it’s great, and I think it makes the fan base feel both inspired and maybe divided, and that’s also great.”

    “Books are hard,” she goes on. “Everybody has their own image of what the story is. I hope people feel inspired in one direction or another.” When asked about what’s next after “Verity,” Johnson teased a very exciting project she already has lined up but can’t disclose further details for now. Watch this space. 

    Continue Reading

  • Why does Mars look purple, yellow and orange in ESA’s stunning new satellite image?

    Why does Mars look purple, yellow and orange in ESA’s stunning new satellite image?

    Despite being known as the Red Planet, Mars shows off its swirling yellows, oranges and browns in a new satellite photo from the European Space Agency (ESA). The Earth-toned surface also reveals an impact crater and four sneaky dust devils making their way across the region.

    The Rothko-like image was taken by a high-resolution camera on ESA’s Mars Express orbiter and captures Arcadia Planitia, an area of Mars critical to research about the planet’s past and its potential to house humans in the future.

    Arcadia Planitia

    Continue Reading

  • Delta kicks off second-quarter earnings this week. But is 2025 already a ‘lost year’ for airlines? – MarketWatch

    1. Delta kicks off second-quarter earnings this week. But is 2025 already a ‘lost year’ for airlines?  MarketWatch
    2. Navigating Trade Headwinds: How Delta, Conagra, and Levi Are Testing Corporate Resilience Ahead of Key Earnings  AInvest
    3. Seeking Clues to Delta (DAL) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics  Nasdaq
    4. Delta Stock Rallies Off Lows Ahead Of Earnings; Byrna Technologies, AZZ Also On The Calendar  MSN
    5. How To Earn $500 A Month From Delta Air Lines Stock Ahead Of Q2 Earnings  Benzinga

    Continue Reading

  • Visiting Our Neighbor Sedna: Feasibility Study Of A Mission To This Planetoid

    Visiting Our Neighbor Sedna: Feasibility Study Of A Mission To This Planetoid

    Image of Sedna, taken by the Hubble Space telescope in 2004. (Credit: NASA)

    While for most people Pluto is the most distant planet in the Solar System, things get a lot more fuzzy once you pass Neptune and enter the realm of trans-Neptunian objects (TNOs). Pluto is probably the most well-known of these, but there are at least a dozen more of such dwarf planets among the TNOs, including 90377 Sedna.

    This obviously invites the notion of sending an exploration mission to Sedna, much as was done with Pluto and a range of other TNOs through the New Horizons spacecraft. How practical this would be is investigated in a recent study by [Elena Ancona] and colleagues.

    The focus is here on advanced propulsion methods, including nuclear propulsion and solar sails. Although it’s definitely possible to use a similar mission profile as with the New Horizons mission, this would make it another long-duration mission. Rather than a decades-long mission, using a minimally-equipped solar sail spacecraft could knock this down to about seven years, whereas the proposed Direct Fusion Drive (DFD) could do this in ten, but with a much larger payload and the ability do an orbital insertion which would obviously get much more science done.

    As for the motivation for a mission to Sedna, its highly eccentric orbit that takes it past the heliopause means that it spends relatively little time being exposed to the Sun’s rays, which should have left much of the surface material intact that was present during the early formation of the Solar System. With our explorations of the Solar System taking us ever further beyond the means of traditional means of space travel, a mission to Sedna might not only expand our horizons, but also provide a tantalizing way to bring much more of the Solar System including the Kuiper belt within easy reach.

    Continue Reading

  • Delta kicks off second-quarter earnings this week. But is 2025 already a ‘lost year’ for airlines?

    Delta kicks off second-quarter earnings this week. But is 2025 already a ‘lost year’ for airlines?

    By Bill Peters

    ‘While the broader macro environment has been more resilient than feared, overall airline-industry demand has looked tepid,’ analyst says

    The second-quarter earnings season will begin a little more quietly than usual this week, with results from Delta Air Lines Inc. due on Thursday.

    Wall Street’s advice? Keep expectations low.

    TD Cowen analyst Tom Fitzgerald, in a research note last week, cited “stable” but also “tepid” demand for flight tickets, as the U.S.’s trade wars and related negotiations keep people anxious over the broader economy. And as the peak summer travel season picks up, he said he isn’t expecting much from airline stocks.

    “We believe U.S. airline shares will be biased downward over the near term due to persistent pricing weakness,” Fitzgerald said. “We do not expect them to catch a bid until there’s greater clarity on consumer demand and 2026 industry pricing. This year increasingly looks like a lost year.”

    Among headwinds, New Jersey’s Newark Liberty International Airport – a major hub serving the New York metro area – has suffered from dropped connections in its communications network, understaffing among air-traffic controllers and runway repairs that have snarled travel. Similar issues have emerged at other airports, while geopolitical conflicts in the Middle East have threatened to push fuel prices higher.

    The airline industry is expected to trim flight schedules to stay in line with weaker demand. Delta (DAL) Chief Executive Ed Bastian, during the company’s earnings call in April, said that “given broad economic uncertainty around global trade, growth has largely stalled.”

    “The impact has been most pronounced in domestic, and specifically in the main cabin, with softness in both consumer and corporate travel,” he added.

    As MarketWatch noted last week, analysts expect premium seating classes and other high-end offerings – which Delta has focused more on in recent years – to fare better than demand in the main cabin. They also expect international travel to outperform domestic travel. Those trends could help better shield the three major U.S. carriers – Delta, United Airlines Holdings Inc. (UAL) and American Airlines Group Inc. (AAL) – from the worst of the industry’s current threats to sales and profits.

    More extensive detail on the state of the economy and the consumer will come next week, when JPMorgan Chase & Co. (JPM) and some of the other big banks report results. Those banks have typically reported during the same week as Delta.

    Still, even as the economy holds up, Delta’s shares are down around 16% so far this year.

    “While the broader macro environment has been more resilient than feared, overall airline-industry demand has looked tepid,” Fitzgerald said.

    The call to put on your calendar

    Levi’s and the tariff deadline: Levi Strauss & Co. (LEVI) reports quarterly results on Thursday. Those results, and the conference call that executives will hold with analysts afterward, could offer more context on the aftermath of July 9, when a 90-day break from the steepest U.S. tariffs on other nations is set to end.

    Analysts have said Levi’s has enough levers to pull to offset most of the tariffs – including more leeway to keep prices higher – and noted that the company had gained popularity with younger shoppers as it tries to sell more clothing besides jeans. The U.S. last week announced a trade deal with Vietnam, where a lot of shoes and clothes get made. But some analysts say that deal likely sets the stage for more tariff hikes on other nations who also produce much of the apparel sold in the U.S.

    During Levi’s earnings call in April, executives said China accounted for around 1% of the goods that the company brought into the U.S., with some 5% from Mexico and “mid-to-high single digits” from Vietnam. They added that nations like Bangladesh, Cambodia, Egypt, Pakistan and Sri Lanka were also essential to its manufacturing.

    The number to watch

    Costco’s monthly sales growth: Costco Wholesale Corp. (COST) is set to release sales figures for the month of June on Wednesday. The membership warehouse chain typically puts out those results with little fanfare. But analysts will be watching for signs of growth, or lack thereof, as shoppers stay budget-conscious amid higher prices and worries about the economy.

    Elsewhere, results during the week from packaged-foods company Conagra Brands Inc. (CAG) will provide an indirect look at consumer behavior in the grocery store.

    -Bill Peters

    This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

    (END) Dow Jones Newswires

    07-06-25 1000ET

    Copyright (c) 2025 Dow Jones & Company, Inc.

    Continue Reading

  • Access ChatGPT, Gemini, and More With a One-Time Payment of Just $30 – PCMag

    1. Access ChatGPT, Gemini, and More With a One-Time Payment of Just $30  PCMag
    2. Pay once and get ChatGPT, Gemini, and more for life with 1min.AI  BleepingComputer
    3. All your favorite AI tools, all in one place for life for $30 during this limited-time sale (Reg. $234)  9to5Toys
    4. ChatGPT is fine I guess, but this basically gives you your own robot army for life  Boing Boing
    5. Get Lifetime Access to This New AI Platform With Just One Payment  extremetech.com

    Continue Reading

  • Gold price outlook: Fed policy, July 9 tariff deadline and data cues may swing yellow metal; analysts see long-term bullish case

    Gold price outlook: Fed policy, July 9 tariff deadline and data cues may swing yellow metal; analysts see long-term bullish case

    Gold prices are likely to witness sharp fluctuations in the coming week as investors brace for key global triggers, including the US Federal Reserve’s policy signals, the July 9 deadline on suspended US tariffs, and crucial economic data releases, analysts said.“Traders are expected to stay cautious ahead of any major policy cues or geopolitical developments, with these factors likely to influence the near-term trajectory of gold prices,” analysts told PTI.The 90-day suspension of Trump-era tariffs on imports from several countries, including India, ends on July 9. If not extended, the suspension’s expiry could revive a 26 per cent additional duty on Indian goods entering the US, a move that could rattle markets.Central bank policy, trade signals in spotlightAccording to Pranav Mer, Vice President, EBG, Commodity & Currency Research at JM Financial Services Ltd, the immediate market focus will be on any rate cut commentary from the US Federal Reserve, outcomes from US trade negotiations, and fresh macroeconomic data from key economies — all of which could weigh heavily on gold in the short term, the agency reported.Investors are also eyeing the minutes of the Fed’s FOMC (Federal Open Market Committee) meeting due this week, which may provide more clarity on the timing and magnitude of future rate cuts.On the MCX, gold futures for August delivery rose by Rs 1,563, or 1.61 per cent, last week.Dollar strength may cap gains, but volatility expectedIn the global market, gold is currently trading around $3,345 per ounce. However, solid US macroeconomic data has tempered expectations of a July interest rate cut, said N S Ramaswamy, Head of Commodities Desk and CRM at Ventura.“Despite some corrective rallies, the short-term outlook favours consolidation and corrective upward movements, followed by a likely continuation of the broader downward trend,” Ramaswamy noted.At the same time, he said that growing fiscal deficit concerns in the US and the potential return of Trump tariffs could drive fresh volatility and revive safe-haven demand for the yellow metal.Dollar weakness, ETF inflows and central bank buying support bullish casePrathamesh Mallya, DVP, Research, Non-Agri Commodities and Currencies at Angel One, said a weakening US dollar and ongoing geopolitical tensions have been key drivers of gold prices in both 2024 and 2025.“Dollar weakness has been a key part of gold prices rising in 2024 as well as in 2025. This trend will continue for the rest of the year,” said Mallya.According to Mer, central banks added a net 20 tonnes of gold to global reserves in May, reinforcing the precious metal’s appeal as a long-term hedge. He also highlighted strong inflows from retail and institutional investors via ETFs as supportive of a bullish outlook.In the first half of 2025, gold has outperformed all major asset classes, clocking gains of nearly 25 per cent, Mer added.(Disclaimer: Recommendations and views on the stock market and other asset classes given by experts are their own. These opinions do not represent the views of The Times of India)


    Continue Reading

  • “We’re Seeing Something Massive Out There”: Astronomers Detect Possible Ninth Planet Beyond Neptune in Chilling New Discovery

    “We’re Seeing Something Massive Out There”: Astronomers Detect Possible Ninth Planet Beyond Neptune in Chilling New Discovery

    IN A NUTSHELL
    • 🔭 Astronomers may have identified a promising candidate for the elusive Planet Nine, found beyond Neptune.
    • 🛰️ The discovery was made by analyzing archival data from the Infrared Astronomical Satellite (IRAS) and the AKARI satellite.
    • ⚖️ Despite the excitement, there is significant skepticism regarding the candidate’s orbit, which does not align with predictions for Planet Nine.
    • 🔍 The upcoming Vera C. Rubin Observatory could provide definitive evidence to confirm or refute the existence of this mysterious planet.

    The quest for discovering the elusive Planet Nine has captivated astronomers and the public alike for years. Recent findings have rekindled this excitement, as astronomers claim they have identified a promising candidate for this mysterious celestial body. While this potential discovery is thrilling, skepticism remains. Is this the breakthrough we’ve been waiting for, or just another cosmic mirage?

    The Search for Planet Nine: A Cosmic Puzzle

    The theory of Planet Nine emerged to explain the unusual orbits of certain objects in the Kuiper Belt, a region beyond Neptune filled with icy bodies. The existence of a large, unseen planet could account for the gravitational forces affecting these orbits. However, proving this hypothesis has been an astronomical challenge. Despite numerous efforts, direct observational evidence remains elusive.

    Recently, researchers delved into archival data from old satellite missions to hunt for Planet Nine. By analyzing infrared images from the 1983 Infrared Astronomical Satellite (IRAS) and the 2006-2011 AKARI satellite, they identified a peculiar dot moving across the sky. This dot, consistent with a distant planet’s movement, has sparked renewed hope in the scientific community.

    A depiction of the imagined Planet Nine within our solar system.

    “A.I. Cracks the Black Hole Code”: Astronomers Use Artificial Intelligence to Reveal Hidden Forces at the Heart of the Universe

    Controversy and Skepticism: A Divided Community

    The prospect of a ninth planet is undeniably exciting, but it is not without controversy. Renowned astronomer Mike Brown, who was instrumental in proposing the Planet Nine hypothesis, remains skeptical about the recent findings. Brown’s calculations suggest that the object’s orbit does not align with the predicted path of Planet Nine, casting doubt on its identity as the hypothesized planet.

    Brown’s skepticism is rooted in the significant tilt of the object’s orbit, which deviates from the expected 15 to 20 degrees. This misalignment implies that the newfound object may not exert the gravitational influence necessary to explain the Kuiper Belt’s anomalies. Despite these discrepancies, the astronomical community remains cautiously optimistic, recognizing that further observations could provide clarity.

    “Mars Lost Its Water Here”: NASA Captures Ancient Blast That May Explain How the Red Planet Turned Into a Dusty Wasteland

    Analyzing the Data: From Dots to Planets

    Transforming a mere dot in the sky into a recognized planet requires meticulous analysis. The team behind the recent study painstakingly sifted through satellite data, identifying potential candidates for Planet Nine. After eliminating known objects, they focused on a single dot that appeared in both the IRAS and AKARI datasets.

    This candidate, characterized by consistent colors and brightness across images, suggests the presence of a singular object captured by both satellites. However, follow-up observations are crucial to determine the object’s full orbit and confirm its planetary status. The scientific method demands rigorous verification, and this potential discovery is no exception.

    James Webb Telescope Unlocks the Deep Structural Secrets of Disk Galaxies, Revealing How the Universe Built Its Greatest Shapes

    The Future of Planetary Discovery: New Horizons

    The search for Planet Nine is set to enter a new era with the advent of the Vera C. Rubin Observatory in Chile. Equipped with the world’s largest digital camera, this state-of-the-art facility will peer deeper into space than ever before. Scheduled to open in 2025, the observatory may finally offer definitive evidence regarding Planet Nine’s existence.

    Researchers anticipate that the observatory’s enhanced capabilities will either confirm the presence of Planet Nine or debunk the hypothesis altogether. This pivotal moment in astronomy could reshape our understanding of the solar system’s architecture, bringing us closer to unraveling the mysteries of the cosmos.

    The quest for Planet Nine epitomizes the relentless human spirit to explore the unknown. As astronomers continue their search, the potential discovery of this enigmatic planet could revolutionize our understanding of the solar system. Will the Vera C. Rubin Observatory finally settle the debate, or will Planet Nine remain an elusive specter in the vast expanse of space? The answer may be just around the cosmic corner.

    Our author used artificial intelligence to enhance this article.

    Did you like it? 4.4/5 (27)

    Continue Reading

  • Horror details as star’s friend dead at 29 – News.com.au

    1. Horror details as star’s friend dead at 29  News.com.au
    2. Cops say speed was a factor in Sophia Hutchins’ ATV crash as friend Caitlyn Jenner battles ‘tough times’  Daily Mail
    3. Caitlyn Jenner’s Friend and Manager, Sophia Hutchins Dead at 29  TMZ
    4. Caitlyn Jenner breaks silence as police reveal details in Sophia Hutchins’ fatal ATV crash  The Express Tribune
    5. Sophia Hutchins Dies In ATV Accident: Caitlyn Jenner’s Manager Was 29  Deadline

    Continue Reading

  • Why Rob Lowe Wants More People to Join Cancer Clinical Trials

    Why Rob Lowe Wants More People to Join Cancer Clinical Trials

    Share on Pinterest
    Actor Rob Lowe has teamed up with Eli Lilly to encourage more people to participate in cancer clinical trials. Photography courtesy of Rob Lowe
    • Rob Lowe shares how three generations of women in his family passed away from breast cancer.
    • The acclaimed actor has partnered with Eli Lilly to spread awareness about the benefits of cancer clinical trials.
    • Lowe’s grandmother benefited from participating in two clinical trials for breast cancer.

    Iconic actor Rob Lowe credits his grandmother, Mim, for his love of reading.

    “My earliest memories are her reading me my favorite book, ‘Peter Rabbit,’ while she sipped her Sanka,” he told Healthline. “I always wanted to have my own coffee, so she would make me a cup of milk and then put a little drop of Sanka in it so it would look like coffee.”

    When he was 10 years old, Mim was diagnosed with breast cancer, the same disease her mother had endured.

    “It was almost a death sentence,” Lowe said.

    After a cancer recurrence, Mim entered a clinical trial, which Lowe said extended her life. Years later, she participated in a second clinical trial. “Both times had tremendous, tremendous success, and it was a very pivotal moment in my upbringing that I always remember,” he said.

    Following his grandmother’s diagnosis, Lowe’s mother was also diagnosed with breast cancer. He said her standard of care was an improvement compared to his grandmother’s.

    “There are amazing advances in medicine, particularly breast cancer, and what I’ve seen going through this three times is tremendous enhancements,” Lowe said, noting the impact clinical trials have had on cancer treatments.

    In honor of the three generations of women he lost to breast cancer, Lowe teamed up with Eli Lilly to bring awareness to the urgent need for more people to participate in cancer clinical trials.

    “I thought this was a great way to remember and keep my grandma Mim’s memory alive,” he said.

    Clinical trials offer hope to people with cancer. For instance, a new breast cancer vaccine is showing effectiveness in clinical trials at preventing and treating breast cancer. The vaccine works by training the immune system to recognize and eliminate cancerous cells before they develop into invasive tumors.

    “Participating in a trial can provide access to cutting-edge drugs that are not yet on the market, improve quality of life, and advance science. The trials of today are the treatments of tomorrow,” Davendra Sohal, MD, associate director for Clinical Research at the University of Cincinnati Cancer Center, told Healthline.

    Clinical trials are used for all types and stages of breast cancer. People can join any phase of a trial if they meet the criteria, which is based on multiple factors, including type of disease, age, medical history, and current medical condition.

    • certain beliefs or lack of trust
    • distance to trial sites
    • insufficient health insurance coverage
    • language barriers
    • immigration status

    In addition to barriers, new treatments developed in clinical trials face a long road before they’re approved for use in the real world.

    “New treatments are studied for lengthy periods of time, typically years, before they receive FDA approval,” Irene M. Kang, MD, medical director of women’s oncology at City of Hope Orange County, told Healthline. “This is why clinical trials are critical for studying new drugs, medical devices, products, and additional treatments before they may become standard of care.”

    If you want to know more about clinical trials, Lowe encourages you to ask your doctor.

    “[There’s] so much hope out there, and it’s not an end-of-the-road ask. If it’s the beginning of the road, ask your doctor,” he said.

    Healthline spoke with Lowe to learn more about the women in his life who were diagnosed with breast cancer and his passion for participating in clinical trials.

    This interview has been edited and condensed for clarity and length.

    Lowe: My number one thing is that all patients have to advocate for themselves. It is the number one game changer in the path you have ahead of you — your ability to advocate, to ask questions, to champion, and guide your own recovery is critical.

    Doctors are only as good as the information they get and the questions that they’re asked. One of them that a lot of people don’t ask is: Is there a clinical trial that can be helpful for me? It’s very simple. Less than 7% of patients do it. That number needs to be much, much, much higher.

    I would also add that I think one of the reasons that there’s some [hesitation] is that I think people feel like “well, if I’m in a clinical trial, maybe I’m going to get a placebo and I actually want treatment.”

    Well, in cancer clinical trials, you get the standard of care. You’re not going to not get the standard of care. You may get a cutting-edge new care in addition, and to me, that’s a no-brainer.

    Continue Reading